4//SEC Filing
O'Day Daniel Patrick 4
Accession 0001638643-25-000007
CIK 0000882095other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 7:38 PM ET
Size
8.3 KB
Accession
0001638643-25-000007
Insider Transaction Report
Form 4
O'Day Daniel Patrick
DirectorChairman & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-09-10+10,427→ 606,152 total - Tax Payment
Common Stock
2025-09-10$115.25/sh−4,949$570,372→ 601,203 total - Exercise/Conversion
Restricted Stock Unit
2025-09-10−10,427→ 98,496 total→ Common Stock (10,427 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
Documents
Issuer
GILEAD SCIENCES, INC.
CIK 0000882095
Entity typeother
Related Parties
1- filerCIK 0001638643
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 7:38 PM ET
- Size
- 8.3 KB